Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 761-766

  Mao, Qiqi ^a   Zheng, Xiangyi ^a   Jia, Xiaolong ^a   Wang, Yuyong ^a   Qin, Jie ^a   Yang, Kai ^a   Bai, Yu ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

China; Prostate; Prostatic hyperplasia prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHINA; COHORT STUDIES; CONFIDENCE INTERVALS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77954564759     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9533-1     Document Type: Article

References (18)

1. Walsh PC (1984) Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res 145:1-25
2. Boyle P, Gould AL, Roehrborn CG (1996) Prostate volume predicts outcome of treatment of benign prostatic hyper-plasia with finasteride: meta-analysis of randomized clinical trials. Urology 48(3):398-105. doi:10.1016/S0090-4295(96) 00353-6 (Pubitemid 26317480)
3. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA et al (1997) Natural history of prostatism: risk factors for acute urinary retention. J Urol 158(2):481-187. doi:10.1016/S0022-5347(01)64508-7 (Pubitemid 27327692)
4. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH et al (1999) Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 53(3):473-180. doi:10.1016/S0090-4295(98)00654-2 (Pubitemid 29136187)
5. Bosch JL, Bohnen AM, Groeneveld FP, Bernsen R (2005) Validity of three calliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: the Krimpen study. Prostate 62(4):353-363. doi:10.1002/pros.20r144
6. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J (1999) Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53(3):581-589. doi:10.1016/S0090-4295(98)00655-4 (Pubitemid 29136206)
7. Hochberg DA, Armenakas NA, Fracchia JA (2000) Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate 45(4):315-319. doi:10.1002/1097- 0045(20001 201)45:43.0.CO;2-2
8. Wang MC, Valenzuela LA, Murphy GP, Chu TM (1979) Purification of a human prostate specific antigen. Invest Urol 17(2):159-163
9. Gupta A, Aragaki C, Gotoh M, Masumori N, Ohshima S, Tsukamoto T et al (2005) Relationship between prostate specific antigen and indexes of prostate volume in Japanese men. J Urol 173(2):503-506. doi:10.1097/01.ju.00001489 07.92910.4d
10. Chang YL, Lin AT, Chen KK, Chang YH, Wu HH, Kuo JY et al (2006) Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia. J Urol 176(1):196-199. doi:10.1016/S0022-5347(06)00568-4 (Pubitemid 43833176)
11. Lee SE, Chung JS, Han BK, Moon KH, Hwang SI, Lee HJ et al (2008) Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia. Urology 71(3):395-398. doi: 10.1016/j.urology.2007.10.019 (Pubitemid 351374707)
12. Furuya Y, Ohta S, Sato N, Kotake T, Masai M (2001) Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia. Int Urol Nephrol 33(4):645-648. doi:10.1023/A:1020539404686 (Pubitemid 35282652)
13. Di Silverio F, Sciarra A, D'Eramo G, Casale P, Loreto A, Seccareccia F (1998) Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases. Prostate 36(1):1-7. doi:10.1002/(SICI)1097-0045 (19980615)36:11::AID-PROS1 3.0.CO;2-M
14. Lepor H, Shapiro E, Wang B, Liang YC (1996) Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men. Urology 47(1):38-42. doi:10.10r16/S0090-4295(99)80379-3
15. Yu EY, Siegal JA, Meyer GE, Ji XR, Ni XZ, Brawer MK (1997) Histologic differences in benign prostate hyper-plasia between Chinese and American men. Prostate 31(3):175-179. doi:10.1002/(SICI)1097-0045(19970515) 31:3175::AID-PROS53.0.CO;2-K
16. Aoki Y, Arai Y, Maeda H, Okubo K, Shinohara K (2001) Racial differences in cellular composition of benign prostatic hyperplasia. Prostate 49(4):243-250. doi:10.1002/ pros.10019
17. Morote J, Encabo G, López M, de Torres IM (2000) Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable? Eur Urol 38(1):91-95. doi:10.1159/000020258
18. Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ et al (2000) Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology 63(5):905-910. doi:10.1016/j.urology.2003.12.037